Community/Retail

The FDA is eliminating the Risk Evaluation and Mitigation Strategy for type 2 diabetes medications containing rosiglitazone.

James Hoffman, PharmD, MS, FASHP, describes negative trends affecting the pharmacy workforce.

There is one biological factor that may impact the development of a birth control pill for men.

The FDA recently approved the first and only drug available in the United States to reverse the effects of chemotherapy drug overdose.

In my previous column about Scott Weiland's death, I made the point that for every celebrity who gets media coverage for going to rehab, there are thousands of common folk who overdose in silence.

In time for the quit smoking New Year resolutions that are anticipated at the end of this month, the International Pharmaceutical Federation has outlined the wide variety of different ways in which pharmacists can reduce the use of tobacco through a new publication.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how a patient's renal function affects appropriate dosing of new oral anticoagulants.

James Hoffman, PharmD, MS, FASHP, explains how pharmacy practice settings may change going forward.

Walgreens stores will be open until midnight or later through December 24 to help shoppers cut down on the holiday hassle.

The FDA has accepted for review Ocular Therapeutix's new drug application for sustained release dexamethasone to relieve ocular pain in patients post-ophthalmic surgery.

Valeant Pharmaceuticals has announced new fulfillment agreements with Walgreens that will reduce the prices of its branded prescription-based dermatological and ophthalmological products by 10%.

Ralphs Grocery Company is making the medicine used to reverse the effects of a drug overdose available without a prescription in its in-store pharmacies across Southern California.

Placing the opioid overdose antidote naloxone behind pharmacy counters across the United States could provide a catalyst for pharmacists to play a central role as facilitators for drug addiction treatment.

Chikungunya was rarely seen in US travelers before 2006, but the virus has grown more prevalent. Now, almost all states have seen at least one case of the disease in US travelers this year.

Diabetes has a tremendous global impact, but developing nations often struggle to help patients deal with their disease.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.

Early preventive action is key for patients in terms of heart health, and it allows pharmacists to play an important role in disease management.

Joel Marrs, PharmD, BCPS-AQ Cardiology, FASHP, discusses the role of the pharmacist in optimizing care for heart failure with reduced ejection fracture patients.

All MTM services may be billed for, but the question remains: which insurance companies will reimburse them?

Pharmacists have more work to do to educate patients on the importance and efficacy of flu vaccination, a new poll reveals.

A pharmacy must pay $60,000 in a settlement resolving allegations that it violated the Controlled Substances Act and the Combat Methamphetamine Epidemic Act of 2005.

A Massachusetts pharmacist is speaking out about prescription drug abuse and heroin addiction in a new HBO documentary available later this month.

Letters of recommendation are by far the most-valued component of the residency application packet.

James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, outlines how pharmacists can use their knowledge of key trends to patient care improvement efforts.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic gives examples of certain off-label uses for NOACs that seem promising.

The FDA is now allowing civilians to access XSTAT 30 wound dressing, an expandable, multi-sponge product typically used to control life-threatening bleeding in military settings.

Joel Marrs, PharmD, BCPS-AQ Cardiology, FASHP, discusses how the approval of Entresto changed the heart failure care landscape.